Tapentadol (CG5503)
Phase 3
Completed
- Conditions
- Osteoarthritis, KneePain
- Interventions
- First Posted Date
- 2007-01-15
- Last Posted Date
- 2012-04-18
- Target Recruit Count
- 1030
- Registration Number
- NCT00421928
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Phase 2
Completed
- Conditions
- Frontotemporal DementiaPick Complex
- First Posted Date
- 2006-12-27
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 41
- Registration Number
- NCT00416169
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Phase 3
Completed
- Conditions
- Psychotic DisorderSchizoaffective Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-12-18
- Last Posted Date
- 2014-05-09
- Target Recruit Count
- 307
- Registration Number
- NCT00412373
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Phase 3
Completed
- Conditions
- Atrial FibrillationStrokeEmbolism
- Interventions
- Drug: Matching placebo for Rivaroxaban arm (Warfarin placebo)Drug: Matching placebo for Warfarin arm (Rivaroxaban placebo)
- First Posted Date
- 2006-11-27
- Last Posted Date
- 2014-04-29
- Target Recruit Count
- 14269
- Registration Number
- NCT00403767
Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)
Phase 2
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2012-10-04
- Target Recruit Count
- 3490
- Registration Number
- NCT00402597
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2013-09-13
- Target Recruit Count
- 242
- Registration Number
- NCT00402688
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Phase 3
Completed
- Conditions
- Schizoaffective DisorderPsychotic Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-11-08
- Last Posted Date
- 2013-07-29
- Target Recruit Count
- 316
- Registration Number
- NCT00397033
Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
Completed
- Conditions
- Chronic Kidney FailurePure Red-Cell Aplasia
- First Posted Date
- 2006-10-23
- Last Posted Date
- 2014-10-03
- Target Recruit Count
- 15334
- Registration Number
- NCT00391287
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy
Phase 2
Completed
- Conditions
- NeoplasmsAnemia
- First Posted Date
- 2006-10-16
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 57
- Registration Number
- NCT00388336
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
Phase 2
Terminated
- Conditions
- AnemiaNeoplasmsCancer
- Interventions
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2013-07-19
- Target Recruit Count
- 235
- Registration Number
- NCT00386152
© Copyright 2025. All Rights Reserved by MedPath